Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release May 12 2022

May 12, 2022 at 8:00 PM UTC · Issued by Sun Pharmaceutical Industries Limited

Sun Pharma Announces US FDA Approval for Generic Mesalamine Extended Release Capsules.